References
- Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE, Vitiligo Working Group. New discoveries in the pathogenesis and classification of vitiligo. Journal of the American Academy of Dermatology. 2017;77(1):1-13. doi: https://doi.org/10.1016/j.jaad.2016.10.048
- Khaled Ezzedine, Viktoria Eleftheriadou, Whitton M, Nanja van Geel. Vitiligo. The Lancet. 2015;386(9988):74-84. doi: https://doi.org/10.1016/S0140-6736(14)60763-7
- Talsania N, Lamb B, Bewley A. Vitiligo is more than skin deep: a survey of members of the Vitiligo Society. Clinical and Experimental Dermatology. 2010;35(7):736-739. doi: https://doi.org/10.1111/j.1365-2230.2009.03765.x
- Radtke MA, Schäfer I, Gajur A, Langenbruch A, Augustin M. Willingness-to-pay and quality of life in patients with vitiligo. British Journal of Dermatology. 2009;161(1):134-139. doi: https://doi.org/10.1111/j.1365-2133.2009.09091.x
- Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. International Journal of Dermatology. 2012;51(10):1206-1212. doi: https://doi.org/10.1111/j.1365-4632.2011.05377.x
- Zhang Y, Cai Y, Shi M, et al. The Prevalence of Vitiligo: A Meta-Analysis. Oiso N, ed. PLOS ONE. 2016;11(9):e0163806. doi: https://doi.org/10.1371/journal.pone.0163806
- Passeron T, Ortonne JP. Vitiligo and other disorders of hypopigmentation. Dermatology. 4th ed. ELSEVIER. 2018;1087-95
- Reichert Faria A, Tarlé RG, Dellatorre G, Mira MT, Silva de Castro CC. Vitiligo - Part 2 - classification, histopathology and treatment. Anais Brasileiros de Dermatologia. 2014;89(5):784-790. doi: https://doi.org/10.1590/abd1806-4841.20142717
- Ezzedine K, Lim HW, Suzuki T, et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell & Melanoma Research. 2012;25(3):E1-E13. doi: https://doi.org/10.1111/j.1755-148x.2012.00997.x
- Boniface K, Seneschal J, Picardo M, Taïeb A. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy. Clinical Reviews in Allergy & Immunology. 2017;54(1):52-67. doi: https://doi.org/10.1007/s12016-017-8622-7
- Kubelis-López D, Zapata-Salazar N, Said-Fernández S, et al. Updates and new medical treatments for vitiligo (Review). Experimental and Therapeutic Medicine. 2021;22(2). doi: https://doi.org/10.3892/etm.2021.10229
- Malakar S, Dhar S. Spontaneous repigmentation of vitiligo patches distant from the autologous skin graft sites: a remote reverse Koebner’s phenomenon?. Dermatology (Basel, Switzerland). 1998;197(3):274.
- Lai YC, Yew YW, Kennedy C, Schwartz RA. Vitiligo and depression: a systematic review and meta‐analysis of observational studies. British Journal of Dermatology. 2017;177(3):708-718. doi: https://doi.org/10.1111/bjd.15199
- Heisler LK, Pronchuk N, Nonogaki K, et al. Serotonin Activates the Hypothalamic-Pituitary-Adrenal Axis via Serotonin 2C Receptor Stimulation. Journal of Neuroscience. 2007;27(26):6956-6964. doi: https://doi.org/10.1523/jneurosci.2584-06.2007
- Lappalainen J, Zhang L, Dean M, et al. Identification, Expression, and Pharmacology of a Cys23-Ser23 Substitution in the Human 5-HT2C Receptor Gene (HTR2C). Genomics. 1995;27(2):274-279. doi: https://doi.org/10.1006/geno.1995.1042
- Brummett BH, Babyak MA, Williams RB, et al. A Putatively Functional Polymorphism in the HTR2C Gene is Associated with Depressive Symptoms in White Females Reporting Significant Life Stress. Walss-Bass C, ed. PLoS ONE. 2014;9(12):e114451. doi: https://doi.org/10.1371/journal.pone.0114451
- Holmes C, Arranz MJ, Powell JF, Collier DA, Lovestone S. 5-HT2A and 5-HT2C Receptor Polymorphisms and Psychopathology in Late Onset Alzheimer’s Disease. Human Molecular Genetics. 1998;7(9):1507-1509. doi: https://doi.org/10.1093/hmg/7.9.1507
- Holmes C, Arranz M, Collier D, Powell J, Lovestone S. Depression in Alzheimer’s disease: The effect of serotonin receptor gene variation. American Journal of Medical Genetics. 2003;119B(1):40-43. doi: https://doi.org/10.1002/ajmg.b.10068
- Brummett BH, Babyak MA, Jiang R, et al. A Functional Polymorphism in the 5HTR2C Gene Associated with Stress Responses Also Predicts Incident Cardiovascular Events. Ahuja SK, ed. PLoS ONE. 2013;8(12):e82781. doi: https://doi.org/10.1371/journal.pone.0082781
- Temel SG, Ergoren MC, Yilmaz I, Yuruker O, Cobanogullari H, Tosun O, et al. Association of the 5HT-R2C gene Ser23 variation with childhood allergic asthma. The Euro-Biotech Journal. 2022 Jul 1;6(3):126-32.
- Temel SG, Yazici S, Yilmaz İ, et al. Psoriasis and 5HTR2C Gene Polymorphism: Association between Clinical, Demographic and Therapeutic Parameters in the Turkish Population. Acta dermatovenerologica Croatica: ADC. 2021;29(3):121-126. Accessed November 10, 2023. https://pubmed.ncbi.nlm.nih.gov/34990340/
- Enkhtaivan E, Lee CH. Role of Amine Neurotransmitters and Their Receptors in Skin Pigmentation: Therapeutic Implication. International Journal of Molecular Sciences. 2021;22(15):8071. doi: https://doi.org/10.3390/ijms2215807121.
- Gerritsen SM, Akkerman JW, Nijmeijer B, Sixma JJ, Witkop CJ, White J. The Hermansky-Pudlak syndrome. Evidence for a lowered 5-hydroxytryptamine content in platelets of heterozygotes. Scandinavian Journal of Haematology. 1977;18(3):249-256.
- Osinubi O, Grainge MJ, Hong L, et al. The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis. The British Journal of Dermatology. 2018;178(4):863-878. doi: https://doi.org/10.1111/bjd.1604923.
- Nicolaidou E, Antoniou C, Miniati A, et al. Childhood-and later-onset vitiligo have diverse epidemiologic and clinical characteristics. Journal of the American Academy of Dermatology. 2012;66(6):954-958. doi: https://doi.org/10.1016/j.jaad.2011.07.01024.
- Lazzeri L, Colucci R, Cammi A, Dragoni F, Moretti S. Adult Onset Vitiligo: Multivariate Analysis Suggests the Need for a Thyroid Screening. BioMed Research International. 2016;2016(8065765):1-5. doi: https://doi.org/10.1155/2016/806576525.
- Manolache L, Benea V. Stress in patients with alopecia areata and vitiligo. Journal of the European Academy of Dermatology and Venereology. 2007;21(7):921-928. doi: https://doi.org/10.1111/j.1468-3083.2006.02106.x
- Papadopoulos L, Bor R, Legg C, Hawk JL. Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology. Clinical and Experimental Dermatology. 1998;23(6):243-248. doi: https://doi.org/10.1046/j.1365-2230.1998.00384.x
- Silverberg JI, Silverberg NB. Vitiligo disease triggers: psychological stressors preceding the onset of disease. Cutis. 2015;95(5):255-262. https://pubmed.ncbi.nlm.nih.gov/26057504/
- Stojanovich L, Marisavljevich D. Stress as a trigger of autoimmune disease. Autoimmunity reviews. 2008;7(3):209-213. doi: https://doi.org/10.1016/j.autrev.2007.11.00731.
- Salzer BA, Schallreuter KU. Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism. Dermatology (Basel, Switzerland). 1995;190(2):109-115. doi: https://doi.org/10.1159/000246657
- TAÏEB A. Intrinsic and Extrinsic Pathomechanisms in Vitiligo. Pigment Cell Research. 2000;13:41-47. doi: https://doi.org/10.1034/j.1600-0749.13.s8.9.x
- Shalbaf M, Gibbons NCJ, Wood JM, et al. Presence of epidermal allantoin further supports oxidative stress in vitiligo. Experimental Dermatology. 2008;17(9):761-770. doi: https://doi.org/10.1111/j.1600-0625.2008.00697.x
- Schallreuter KU, Wood JM, Berger J. Low Catalase Levels in the Epidermis of Patients with Vitiligo. Journal of Investigative Dermatology. 1991;97(6):1081-1085. doi: https://doi.org/10.1111/1523-1747.ep12492612
- Chiarella P. Vitiligo susceptibility at workplace and in daily life: the contribution of oxidative stress gene polymorphisms. Biomedical Dermatology. 2019;3(1). doi: https://doi.org/10.1186/s41702-019-0043-1
- Slominski AT, Zmijewski MA, Zbytek B, Tobin DJ, Theoharides TC, Rivier J. Key role of CRF in the skin stress response system. Endocrine Reviews. 2013;34(6):827-884. doi: https://doi.org/10.1210/er.2012-1092
- Nordlind K, Azmitia EC, Slominski A. The skin as a mirror of the soul: exploring the possible roles of serotonin. Experimental Dermatology. 2008;17(4):301-311. doi: https://doi.org/10.1111/j.1600-0625.2007.00670.x
- Kurbanov K, Berezov TT. [Tryptophan metabolism in vitiligo]. Voprosy Meditsinskoi Khimii. 1976;22(5):683-687. Accessed November 10, 2023. https://pubmed.ncbi.nlm.nih.gov/1014481/
- Pang S, Wu H, Wang Q, Cai M, Shi W, Shang J. Chronic Stress Suppresses the Expression of Cutaneous Hypothalamic–Pituitary–Adrenocortical Axis Elements and Melanogenesis. Slominski AT, ed. PLoS ONE. 2014;9(5):e98283. doi: https://doi.org/10.1371/journal.pone.0098283
- Wu HL, Pang SL, Liu QZ, Wang Q, Cai MX, Shang J. 5-HT1A/1B Receptors as Targets for Optimizing Pigmentary Responses in C57BL/6 Mouse Skin to Stress. Slominski AT, ed. PLoS ONE. 2014;9(2):e89663. doi: https://doi.org/10.1371/journal.pone.0089663
- Zhou L, Cai M, Ren Y, et al. The different roles of 5-HT1A/2A receptors in fluoxetine ameliorated pigmentation of C57BL/6 mouse skin in response to stress. Journal of Dermatological Science. 2018;92(3):222-229. doi: https://doi.org/10.1016/j.jdermsci.2018.10.002
- Liu L, Fu M, Pei S, Zhou L, Shang J. R-Fluoxetine Increases Melanin Synthesis Through a 5-HT1A/2A Receptor and p38 MAPK Signaling Pathways. International Journal of Molecular Sciences. 2018;20(1):80-80. doi: https://doi.org/10.3390/ijms20010080
- Lee HJ, Park MK, Kim SY, Park Choo HY, Lee AY, Lee CH. Serotonin induces melanogenesis via serotonin receptor 2A. British Journal of Dermatology. 2011;165(6):1344-1348. doi: https://doi.org/10.1111/j.1365-2133.2011.10490.x
- Luis Royo J. Hardy Weinberg Equilibrium Disturbances in Case-Control Studies Lead to Non-Conclusive Results. Cell Journal (Yakhteh). 2021;22(4):572-574. doi: https://doi.org/10.22074/cellj.2021.7195
- Zhang X, Li L, Jiang L, et al. Characteristics and pathogenesis of Koebner phenomenon. Experimental Dermatology. 2022;32(4):310-323. doi: https://doi.org/10.1111/exd.14709